What would it feel like living with cancer and working in a space where I’m trying to help advance cancer therapies?”
On the SHE MD Podcast, CVI Executive Director Dr. Kiran Dhillon recounted her experience of receiving a diagnosis for the very disease she had been studying throughout her professional career. Now, she’s looking to prevent breast cancer using vaccines through research at the CVI.
“Once I started, the overwhelming feeling was hope and joy at looking at the results…I’m inspired by the work we’re doing,” Dr. Dhillon said. As part of Breast Cancer Awareness Month, she highlighted some of the exciting results from the CVI’s breast and ovarian cancer clinical trials and expectations to see the first FDA-approved breast cancer vaccine in the next 5 to 8 years.
Achieving this requires everyone at the table: collaborators, funders, regulators, patients, government, pharma, and the broader public, she said.
This is why the partnership with groups such as the Cancer Vaccine Coalition is crucial. Co-guest Kristen Dahlgren, CEO of the Cancer Vaccine Coalition and former NBC TodayShow correspondent, shared how vaccine research inspired her to leave her media career and focus on helping advance the field — with the goal of bringing these to every patient in need.
Listen to Dr. Dhillon and Dahlgren’s journeys in fighting and finding a cure for cancer: https://www.shemdpodcast.com/episodes/the-cancer-vaccine-new-vaccines-could-stop-breast-cancer-in-its-tracks-with-kristen-dahlgren-dr-kiran-dhillon
Comments